Fremanezumab May Offer Prevention for Refractory Migraine Fremanezumab May Offer Prevention for Refractory Migraine
A CGRP agent in development to prevent chronic migraine demonstrates efficacy in patients previously treated with topiramate or onabotulinumtoxinA.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 16, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Botox Tops Topiramate for Chronic Migraine Prevention Botox Tops Topiramate for Chronic Migraine Prevention
Researchers compared tolerability, functional improvement, and more in a head-to-head comparison between onabotulinumtoxinA and topiramate for chronic migraine prevention.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 16, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Chronic Migraine, Not Treatment, Tied to Cognitive Impairment Chronic Migraine, Not Treatment, Tied to Cognitive Impairment
New research evaluates the possible role of comorbidities and topiramate treatment in cognitive impairment in patients with chronic migraine.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Topiramate for Seizures in Preterm Newborns Linked With Necrotizing Enterocolitis Topiramate for Seizures in Preterm Newborns Linked With Necrotizing Enterocolitis
Out of 10 preterm neonates who received topiramate for seizures, four developed radiographic signs of necrotizing enterocolitis (NEC), according to researchers at the University of Miami Miller School of Medicine.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 21, 2018 Category: Intensive Care Tags: Pediatrics News Source Type: news
What Treatment is Recommended for Common Headaches?
Discussion
Headache is pain in the scalp, forehead, orbits and temple. Facial and neck pain are usually excluded from this definition. It is a common problem with more than 6 million pediatric patients having migraine. Headaches can also have co-morbidities and more than 1 primary headache type can co-exist. The costs are high both economically and in the quality of life for the patients and families. A review of common headache types and indications for neuroimaging can be found here.
Treatment is necessarily multi-pronged. Patients should understand their diagnosis so they can understand what reasonably can be expected...
Source: PediatricEducation.org - January 15, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Topiramate Dose in Mom Affects Oral Cleft Risk in Child Topiramate Dose in Mom Affects Oral Cleft Risk in Child
Higher doses of the drug taken early in pregnancy by women with epilepsy were associated with higher risk for oral clefts in offspring; lower doses used for other indications showed a weaker link.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 5, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Topiramate in early pregnancy increases risk of oral clefts
Risk of cleft lip or cleft palate is greater if mother takes a higher dose of the drug Related items fromOnMedica Adverse pregnancy outcomes far more likely in epilepsy Study reveals mental cost of epilepsy in pregnancy Cannabis derivative cannabidiol reduces seizures in severe epilepsy disorder New guidelines on epilepsy in pregnancy Epilepsy drug linked to 4,000 birth defects in France (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 2, 2018 Category: UK Health Source Type: news
Risk of Oral Clefts with Topiramate May Be Dose-Dependent (CME/CE)
(MedPage Today) -- Higher doses tied to higher risk of cleft lip, palate (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - December 30, 2017 Category: Neurology Source Type: news
The dangers of epilepsy drugs for pregnant women
Harvard Medical School researchers discovered that 12.3 children in every 1,000 are born with an oral cleft for mothers on high doses of topiramate, which is branded as Topamax. (Source: the Mail online | Health)
Source: the Mail online | Health - December 29, 2017 Category: Consumer Health News Source Type: news
Can Devices Replace Drugs for Migraine Treatment?
Migraine headache sufferers, particularly those who suffer from multiple debilitating episodes per month, can now ask their physicians about versatile non-pharmaceutical, non-invasive treatment devices that can both prevent migraines and lessen the severity of acute attacks.
FDA has granted within the past few months expanded use clearance for two devices that work on the principle of neuromodulation. Interestingly enough, one of the devices, manufactured by Belgium-based Cefaly, had been cleared in 2014 for migraine prevention and was granted expanded approval for acute migraine treatment in November; the other, the Sprin...
Source: MDDI - December 29, 2017 Category: Medical Devices Authors: Greg Goth Tags: Electronics Source Type: news
Topiramate in early pregnancy increases risk of oral clefts
(Brigham and Women's Hospital) A new study by investigators from Brigham and Women's Hospital and the Harvard T.H. Chan School of Public Health suggest that using topiramate in early pregnancy, particularly at the high doses used for epilepsy, increases the risk of oral clefts. Their results are published in Neurology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 28, 2017 Category: International Medicine & Public Health Source Type: news
Epilepsy Drug Could Raise Birth Defect Risks
Researchers found that pregnant women with epilepsy who take the drug topiramate during their first trimester may boost the risk that their child will be born with a cleft lip or cleft palate. (Source: WebMD Health)
Source: WebMD Health - December 27, 2017 Category: Consumer Health News Source Type: news
Epilepsy Drug, #Topiramate, Could Raise Birth Defect Risks
WEDNESDAY, Dec. 27, 2017 -- A common anti-seizure drug may pose a birth defect problem for pregnant women, a new study warns.
Researchers found that pregnant women with epilepsy who take the drug topiramate during their first trimester may boost... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 27, 2017 Category: General Medicine Source Type: news
Epilepsy Drug, Topiramate, Could Raise Birth Defect Risks
WEDNESDAY, Dec. 27, 2017 -- A common anti-seizure drug may pose a birth defect problem for pregnant women, a new study warns.
Researchers found that pregnant women with epilepsy who take the drug topiramate during their first trimester may boost... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 27, 2017 Category: General Medicine Source Type: news
Epilepsy Drug Could Raise Birth Defect Risks
WEDNESDAY, Dec. 27, 2017 -- A common anti-seizure drug may pose a birth defect problem for pregnant women, a new study warns.
Researchers found that pregnant women with epilepsy who take the drug topiramate during their first trimester may boost the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 27, 2017 Category: General Medicine Source Type: news
